These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33712541)

  • 21. Intracellular calcium attenuates late current conducted by mutant human cardiac sodium channels.
    Potet F; Beckermann TM; Kunic JD; George AL
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):933-41. PubMed ID: 26022185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. When the Gates Swing Open Only: Arrhythmia Mutations That Target the Fast Inactivation Gate of Na
    Gamal El-Din TM
    Cells; 2022 Nov; 11(23):. PubMed ID: 36496974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Citrus Flavonoid Hesperetin Has an Inadequate Anti-Arrhythmic Profile in the ΔKPQ Na
    Alvarez-Collazo J; López-Requena A; Alvarez JL; Talavera K
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32599724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complex interactions in a novel SCN5A compound mutation associated with long QT and Brugada syndrome: Implications for Na+ channel blocking pharmacotherapy for de novo conduction disease.
    Liu J; Bayer JD; Aschar-Sobbi R; Wauchop M; Spears D; Gollob M; Vigmond EJ; Tsushima R; Backx PH; Chauhan VS
    PLoS One; 2018; 13(5):e0197273. PubMed ID: 29791480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SCN5A(K817E), a novel Brugada syndrome-associated mutation that alters the activation gating of NaV1.5 channel.
    Kinoshita K; Takahashi H; Hata Y; Nishide K; Kato M; Fujita H; Yoshida S; Murai K; Mizumaki K; Nishida K; Yamaguchi Y; Kano M; Tabata T; Nishida N
    Heart Rhythm; 2016 May; 13(5):1113-1120. PubMed ID: 26776555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term flecainide therapy in type 3 long QT syndrome.
    Chorin E; Taub R; Medina A; Flint N; Viskin S; Benhorin J
    Europace; 2018 Feb; 20(2):370-376. PubMed ID: 28339995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting Patient Response to the Antiarrhythmic Mexiletine Based on Genetic Variation.
    Zhu W; Mazzanti A; Voelker TL; Hou P; Moreno JD; Angsutararux P; Naegle KM; Priori SG; Silva JR
    Circ Res; 2019 Feb; 124(4):539-552. PubMed ID: 30566038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring mutation specific beta blocker pharmacology of the pathogenic late sodium channel current from patient-specific pluripotent stem cell myocytes derived from long QT syndrome mutation carriers.
    Comollo TW; Zou X; Zhang C; Kesters D; Hof T; Sampson KJ; Kass RS
    Channels (Austin); 2022 Dec; 16(1):173-184. PubMed ID: 35949058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling incomplete penetrance in long QT syndrome type 3 through ion channel heterogeneity: an in silico population study.
    Miller JA; Moise N; Weinberg SH
    Am J Physiol Heart Circ Physiol; 2023 Feb; 324(2):H179-H197. PubMed ID: 36487185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanistic insights into the interaction of the MOG1 protein with the cardiac sodium channel Na
    Yu G; Liu Y; Qin J; Wang Z; Hu Y; Wang F; Li Y; Chakrabarti S; Chen Q; Wang QK
    J Biol Chem; 2018 Nov; 293(47):18207-18217. PubMed ID: 30282806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional Characterization of Two Novel Mutations in
    Balla C; Conte E; Selvatici R; Marsano RM; Gerbino A; Farnè M; Blunck R; Vitali F; Armaroli A; Brieda A; Liantonio A; De Luca A; Ferlini A; Rapezzi C; Bertini M; Gualandi F; Imbrici P
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Spectrum of SCN5A Mutations: Long QT Syndrome, Brugada Syndrome, and Cardiomyopathy.
    Wilde AAM; Amin AS
    JACC Clin Electrophysiol; 2018 May; 4(5):569-579. PubMed ID: 29798782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The SCN5A mutation A1180V is associated with electrocardiographic features of LQT3.
    Zhang Y; Wang J; Chang S; Zhou N; Xing H; Wang L; Huang C; Ma A; Huang CL; Lei M; Fraser JA
    Pediatr Cardiol; 2014 Feb; 35(2):295-300. PubMed ID: 23963187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SCN5A compound heterozygosity mutation in Brugada syndrome: Functional consequences and the implication for pharmacological treatment.
    Joviano-Santos JV; Santos-Miranda A; Neri EA; Fonseca-Alaniz MH; Krieger JE; Pereira AC; Roman-Campos D
    Life Sci; 2021 Aug; 278():119646. PubMed ID: 34048814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations of Nedd4-2-binding capacity in PY-motif of Na
    Wang Y; Du Y; Luo L; Hu P; Yang G; Li T; Han X; Ma A; Wang T
    Acta Physiol (Oxf); 2020 Jun; 229(2):e13438. PubMed ID: 31900993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrophysiological and trafficking defects of the SCN5A T353I mutation in Brugada syndrome are rescued by alpha-allocryptopine.
    Zhang J; Chen Y; Yang J; Xu B; Wen Y; Xiang G; Wei G; Zhu C; Xing Y; Li Y
    Eur J Pharmacol; 2015 Jan; 746():333-43. PubMed ID: 25261036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Electrophysiological characteristics of a SCN5A voltage sensors mutation R1629Q associated with Brugada syndrome.
    Zeng Z; Zhou J; Hou Y; Liang X; Zhang Z; Xu X; Xie Q; Li W; Huang Z
    PLoS One; 2013; 8(10):e78382. PubMed ID: 24167619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiac sodium channelopathy associated with SCN5A mutations: electrophysiological, molecular and genetic aspects.
    Remme CA
    J Physiol; 2013 Sep; 591(17):4099-116. PubMed ID: 23818691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beneficial effects of chronic mexiletine treatment in a human model of SCN5A overlap syndrome.
    Nasilli G; Yiangou L; Palandri C; Cerbai E; Davis RP; Verkerk AO; Casini S; Remme CA
    Europace; 2023 Jun; 25(6):. PubMed ID: 37369559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel Clinical Manifestation of the Known SCN5A D1790G Mutation.
    Blich M; Efrati E; Marai I; Suleiman M; Gepstein L; Boulous M
    Cardiology; 2015; 132(4):228-32. PubMed ID: 26304620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.